We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Americold
COLD
$4.27B
| $3.51M | ﹤0.01% |
287,040
-30,026
| -9% | -$447K |
|
1602
Enterprise Financial Services Corp
EFSC
$2.39B
| $3.5M | ﹤0.01% |
60,287
-3,712
| -6% | -$216K |
|
1603
Alignment Healthcare
ALHC
$2.98B
| $3.49M | ﹤0.01% |
200,065
+15,382
| +8% | +$228K |
|
1604
Beam Therapeutics
BEAM
$2.84B
| $3.49M | ﹤0.01% |
143,828
-7,544
| -5% | -$150K |
|
|
AUO
1605
DELISTED
AU Optronics Corp
AUO
| $3.49M | ﹤0.01% |
724,885
+105,300
| +17% | +$506K |
|
1606
Transocean
RIG
$5.82B
| $3.48M | ﹤0.01% |
1,115,293
-24,829
| -2% | -$74.9K |
|
1607
Dime Commercial Bancshares
DCOM
$1.78B
| $3.47M | ﹤0.01% |
116,441
-387
| -0.3% | -$11.3K |
|
1608
Upwork
UPWK
$1.19B
| $3.47M | ﹤0.01% |
186,616
-6,583
| -3% | -$98K |
|
1609
Nelnet
NNI
$4.7B
| $3.46M | ﹤0.01% |
27,633
-2,646
| -9% | -$331K |
|
1610
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $3.46M | ﹤0.01% |
80,606
-5,487
| -6% | -$247K |
|
|
SARO
1611
StandardAero Inc
SARO
$9.7B
| $3.46M | ﹤0.01% |
126,631
-8,020
| -6% | -$225K |
|
1612
Arcutis Biotherapeutics
ARQT
$3.18B
| $3.45M | ﹤0.01% |
183,129
-2,970
| -2% | -$46.8K |
|
1613
Freshworks
FRSH
$3.27B
| $3.44M | ﹤0.01% |
292,549
-12,253
| -4% | -$165K |
|
1614
Sarepta Therapeutics
SRPT
$1.77B
| $3.44M | ﹤0.01% |
178,421
-88,893
| -33% | -$1.58M |
|
1615
Universal Corp
UVV
$1.27B
| $3.43M | ﹤0.01% |
61,400
-1,122
| -2% | -$62K |
|
1616
Xometry
XMTR
$5.34B
| $3.43M | ﹤0.01% |
62,976
-1,598
| -2% | -$69.3K |
|
1617
iShares MSCI Kuwait ETF
KWT
$68.4M
| $3.41M | ﹤0.01% |
86,117
+4,837
| +6% | +$189K |
|
1618
Certara
CERT
$1.25B
| $3.4M | ﹤0.01% |
278,479
+14,578
| +6% | +$159K |
|
1619
IDEAYA Biosciences
IDYA
$3.56B
| $3.4M | ﹤0.01% |
124,851
-6,298
| -5% | -$152K |
|
1620
Harmony Biosciences
HRMY
$2.24B
| $3.39M | ﹤0.01% |
122,989
+3,788
| +3% | +$130K |
|
1621
GlobalFoundries
GFS
$29.6B
| $3.39M | ﹤0.01% |
94,513
-2,164
| -2% | -$77.2K |
|
1622
Innodata
INOD
$2.04B
| $3.38M | ﹤0.01% |
43,841
-553
| -1% | -$27.9K |
|
1623
Delek US
DK
$3.58B
| $3.37M | ﹤0.01% |
104,409
-9,900
| -9% | -$259K |
|
1624
iShares S&P 500 Growth ETF
IVW
$77.6B
| $3.37M | ﹤0.01% |
27,880
| – | – |
|
1625
Tarsus Pharmaceuticals
TARS
$2.84B
| $3.36M | ﹤0.01% |
56,523
-1,127
| -2% | -$55.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.